Report Details

Aquaculture Pharmaceuticals Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2019 to 2025

ID : 7745316
Date : May 2019
Pages : 219 Pages
Industry : Food and Beverages


Global Aquaculture Pharmaceuticals Market: By Product type Biologics, Parasiticides, Anti-infectives, Reproduction, and Others, Species Carps, Salmon, Tilapia, Shrimp, Catfish, Trout, and Others and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Aquaculture Pharmaceuticals Market Report Description:
Aquaculture Pharmaceuticals market report gives comprehensive outlook on aquaculture pharmaceuticals across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa MEA. This report on aquaculture pharmaceuticals market gives historical, current, and future market sizes US$ Mn of stimulation system, disease indication, charging system, end-user, and geographic regions. This report studies aquaculture pharmaceuticals market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, Aquaculture Pharmaceuticals market report includes recent product launches, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analysed aquaculture pharmaceuticals market to better equip clients with possible investment opportunities across the regions Regional Investment Hot-Spots and market unmet needs Product Opportunities. Key stakeholders of the aquaculture pharmaceuticals market report include suppliers, manufacturers, marketers, policy makers engaged in manufacturing and supply of aquaculture pharmaceuticals.

Aquaculture Pharmaceuticals Market:
The Aquaculture pharmaceuticals market was valued at US$ 459.2 Mn in 2016 and poised to grow at CAGR 7.4%. over 2019-2025

Lack of generic drugs and increase in farmed fish production makes aquaculture pharmaceuticals more lucrative
Pharmaceuticals plays a pivotal role in aquaculture to prevent and treat aquatic animals from various microbial infections. Companies are betting heavily on research and development programs to develop novel drugs that can treat new infections in aquatic animals. For instance, in 2015, PHARMAQ, a part of Zoetis, Inc., invested in to produce fish vaccines in new facility at Klofta. Furthermore, lack of generic drugs to compete with inventor drugs makes more lucrative for the aquaculture pharmaceuticals manufacturers. In addition, global increase in farmed fish production than the wild catch are projected to boost aquaculture pharmaceuticals market over the forecast period. According to Food and Agriculture Organisation of the United Nations FAO estimates, the farmed fish production increased by 5.6% from 66.5 Mn tonnes 2013 to 70.2 Mn tonnes 2013.

Outbreak of new microbial infections effect the aquaculture pharmaceuticals
Aquaculture industry suffered from many microbial outbreaks that resulted death of many aquatic animals. Lack of drugs/vaccines to new diseases are projected to hamper the growth of the aquaculture pharmaceuticals. Furthermore, antibiotic resistance to the aquatic animals is one of the factors that restraining the growth of aquaculture pharmaceuticals market.

Asia-Pacific accounts for larger market revenue share in global aquaculture pharmaceuticals market
Asia-Pacific market dominates the aquaculture pharmaceuticals owing to increase in aquaculture production. As per the Food and Agriculture Organisation of the United Nations FAO estimates, China is the largest contributor for aquaculture production. It accounts more than 70% of the world’s total production. India, Vietnam, Thailand and Other ASEAN countries are also responsible for the growth of aquaculture pharmaceuticals market in Asia-Pacific region. In Europe, Norway is the key market for the aquaculture pharmaceuticals market.

Competition Assessment
Key player’s profiles in the global aquaculture pharmaceuticals market include:
Elanco Eli Lilly and Company U.S.
Intervet Inc., Merck & Co., Inc., U.S.
Bayer AG Germany
PharmaQ AS Zoetis, Inc.,

Aquaculture pharmaceuticals players emphasizing more on launch new drugs into the market. Furthermore, they are actively expanding their business into new regions specifically on Asia-Pacific as the market more centered towards the region. For instance, in 2012, Intervet Inc., a subsidiary of Merck & Co., AQUAVAC IridoV, received the market authroisation in Singapore to boost their immunity against iridovirus. Company also recently launched AQUAVAC Strep Sa vaccine in Indonesia that protects tilapia and other fishes from Streptococcus agalactiae infections. In June 2018, Elanco Eli and Lilly Company Clynav got market authorization from the European Commission. Clynav is the first DNA vaccine that can protect the Salmon from salmanoid alphavirus subtype 3 SAV 3.

Key Findings of the Report:
Aquaculture Pharmaceuticals market expanding at XX% CAGR over 2018 to 2013 to reach market value of US$ XX Mn by 2025
Based on product type, biologics accounted for larger market share in 2016 owing to their usage in aquaculture to prevent aquatic animals from microbial infections
Salmon and Tilapia segment projected to be most lucrative market in global aquaculture pharmaceuticals market
Players focusing on inorganic growth to enhance their market share

Key Features of the Report:
The report provides granular level information about the market size, regional market share, historic market 2014-2018 and forecast 2019-2025
The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startup’s details that are actively working in the market
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Detailed Segmentation
By Product
Biologics
Parasiticides
Anti-infectives
Reproduction
Others

By Species
Carps
Salmon
Tilapia
Shrimp
Catfish
Trout
Others

Geography
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Russia
Poland
Rest of Europe
Asia-Pacific
Japan
China
India
Australia & New Zealand
ASEAN Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Argentina
Venezuela
Rest of Latin America
Middle East and Africa MEA
Gulf Cooperation Council GCC Countries
Israel
South Africa
Rest of MEA
1. Executive summary
2. Global Aquaculture Pharmaceuticals Market Introduction
2.1. Global Aquaculture Pharmaceuticals Market – Taxonomy
2.2. Global Aquaculture Pharmaceuticals Market –Definitions
2.2.1. Product
2.2.2. Species
3. Global Aquaculture Pharmaceuticals Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Aquaculture Pharmaceuticals Market Dynamics – Factors Impact Analysis
3.6. Global Aquaculture Pharmaceuticals Market – Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.6.4. China
3.7. Global Aquaculture Pharmaceuticals Market – Product Innovations
4. Global Aquaculture Pharmaceuticals Market Analysis, 2014 - 2018 and Forecast, 2019 – 2025
4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
4.2. Year-over-Year Y-o-Y Growth Analysis %
4.3. Market Oppurtunity Analysis
5. Global Aquaculture Pharmaceuticals Market, By Product, 2014 - 2018 and Forecast, 2019 - 2025
5.1. Biologics
5.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
5.1.3. Market Opportunity Analysis
5.2. Parasiticides
5.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
5.2.3. Market Opportunity Analysis
5.3. Anti-infectives
5.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.3.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
5.3.3. Market Opportunity Analysis
5.4. Reproduction
5.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.4.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.5.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
5.5.3. Market Opportunity Analysis
6. Global Aquaculture Pharmaceuticals Market Forecast, By Species, 2014 - 2018 and Forecast, 2019 - 2025
6.1. Carps
6.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
6.1.3. Market Opportunity Analysis
6.2. Salmon
6.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.3. Tilapia
6.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.3.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
6.3.3. Market Opportunity Analysis
6.4. Shrimp
6.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.4.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
6.4.3. Market Opportunity Analysis
6.5. Catfish
6.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.5.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
6.5.3. Market Opportunity Analysis
6.6. Trout
6.6.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.6.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
6.6.3. Market Opportunity Analysis
6.7. Others
6.7.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.7.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
6.7.3. Market Opportunity Analysis
7. Global Aquaculture Pharmaceuticals Market Forecast, By Region, 2014 - 2018 and Forecast, 2019 - 2025
7.1. North America
7.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.3.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.4.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.5.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis
7.5.3. Market Opportunity Analysis
7.6. Global Aquaculture Pharmaceuticals Market - Opportunity Analysis Index, By Product, Species, and Region, 2019 – 2025
8. North America Aquaculture Pharmaceuticals Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
8.1. Product Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth %, and Market Share %
8.1.1. Biologics
8.1.2. Parasiticides
8.1.3. Anti-infectives
8.1.4. Reproduction
8.1.5. Others
8.2. Species Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
8.2.1. Carps
8.2.2. Salmon
8.2.3. Tilapia
8.2.4. Shrimp
8.2.5. Catfish
8.2.6. Trout
8.2.7. Others
8.3. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn Y-o-Y Growth % and Market Share %
8.3.1. U.S.
8.3.2. Canada
8.4. North America Aquaculture Pharmaceuticals Market - Opportunity Analysis Index, By Product, Species, and Country, 2019 – 2025
8.5. North America Aquaculture Pharmaceuticals Market Dynamics – Trends
9. Europe Aquaculture Pharmaceuticals Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
9.1. Product Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth %, and Market Share %
9.1.1. Biologics
9.1.2. Parasiticides
9.1.3. Anti-infectives
9.1.4. Reproduction
9.1.5. Others
9.2. Species Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
9.2.1. Carps
9.2.2. Salmon
9.2.3. Tilapia
9.2.4. Shrimp
9.2.5. Catfish
9.2.6. Trout
9.2.7. Others
9.3. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Aquaculture Pharmaceuticals Market - Opportunity Analysis Index, By Product, Species, and Country, 2019 – 2025
9.5. Europe Aquaculture Pharmaceuticals Market Dynamics – Trends
10. Asia-Pacific Aquaculture Pharmaceuticals Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
10.1. Product Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth %, and Market Share %
10.1.1. Biologics
10.1.2. Parasiticides
10.1.3. Anti-infectives
10.1.4. Reproduction
10.1.5. Others
10.2. Species Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.2.1. Carps
10.2.2. Salmon
10.2.3. Tilapia
10.2.4. Shrimp
10.2.5. Catfish
10.2.6. Trout
10.2.7. Others
10.3. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn,
Y-o-Y Growth %, and Market Share %
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Aquaculture Pharmaceuticals Market - Opportunity Analysis Index, By Product, Species, and Country, 2019 – 2025

10.5. Europe Aquaculture Pharmaceuticals Market Dynamics – Trends
11. Latin America Aquaculture Pharmaceuticals Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
11.1. Product Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth %, and Market Share %
11.1.1. Biologics
11.1.2. Parasiticides
11.1.3. Anti-infectives
11.1.4. Reproduction
11.1.5. Others
11.2. Species Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.2.1. Carps
11.2.2. Salmon
11.2.3. Tilapia
11.2.4. Shrimp
11.2.5. Catfish
11.2.6. Trout
11.2.7. Others
11.3. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Venezuela
11.3.5. Rest of Latin America
11.4. Latin America Aquaculture Pharmaceuticals Market - Opportunity Analysis Index, , By Product, Species, and Country, 2019 – 2025
11.5. Latin America Aquaculture Pharmaceuticals Market Dynamics – Trends
12. Middle East and Africa Aquaculture Pharmaceuticals Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
12.1. Product Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth %, and Market Share %
12.1.1. Biologics
12.1.2. Parasiticides
12.1.3. Anti-infectives
12.1.4. Reproduction
12.1.5. Others
12.2. Species Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.2.1. Carps
12.2.2. Salmon
12.2.3. Tilapia
12.2.4. Shrimp
12.2.5. Catfish
12.2.6. Trout
12.2.7. Others
12.3. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth %, and Market Share %
12.3.1. Gulf Cooperation Council GCC Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Aquaculture Pharmaceuticals Market - Opportunity Analysis Index, By Product, Species, and Country, 2019 – 2025
12.5. MEA Aquaculture Pharmaceuticals Market Dynamics – Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis

13.2.1. Elanco Eli Lilly and Company U.S.
13.2.2. Intervet Inc., Merck & Co., Inc., U.S.
13.2.3. Bayer AG Germany
13.2.4. PharmaQ AS Zoetis, Inc.,

14. Research Methodology
15. Key Assumptions and Acronyms


Please fill the following form to know more details about this Report




RELATED PRODUCTS



CHOOSE A FORMAT


  •  Single User Price : $ 4400
  •  Enterprise User License : $ 6600
  •  Corporate User License : $ 8900

Have A Question ?


  DOWNLOAD SAMPLE



TESTIMONIALS

I am completely satisfied with the information given in the sample pages of the report and I am waiting for the affirmative response from my peers and colleagues to purchase it.hey answered to all my queries promptly. I am highly satisfied!!
John Keats
We received a very quick response to all our queries on the RTLS report and we were also given a free consult with analyst for 15 minutes. It is refreshing (and increasingly rare) to have a new company go the extra mile to win the confidence of the customer
Ernest Hemingway
I would like to express my gratitude for the excellent service received this morning from the support team. They acknowledged my concern of adding me to the secondary user's list immediately. Thank you for this excellent, speedy and thoughtful service
Jacob Watson

CUSTOM RESEARCH

Still haven't found what you're looking for ?
Speak to our Custom Research Team